Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoadjuvant Therapy
Neoplasm Staging
Chemotherapy, Adjuvant
Feasibility Studies
Radiotherapy, Adjuvant
Fluorouracil administration
Clinical Trials, Phase III as Topic
Rectal Neoplasms drug therapy
Rectum pathology
Humans
Randomized Controlled Trials as Topic
dosage
Combined Modality Therapy
Disease Progression
Clinical Trials, Phase II as Topic
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoadjuvant Therapy
Neoplasm Staging
Chemotherapy, Adjuvant
Feasibility Studies
Radiotherapy, Adjuvant
Fluorouracil administration
Clinical Trials, Phase III as Topic
Rectal Neoplasms drug therapy
Rectum pathology
Beschreibung:
in the era of preoperative chemoradiotherapy (CRT) and total mesorectal excision (TME), the development of distant metastases is the predominant mode of failure in rectal cancer patients today. Integrating more effective systemic therapy into combined modality programs is the challenge. The question that needs to be addressed is how and when to apply systemic treatment with adequate dose and intensity.
in the era of preoperative chemoradiotherapy (CRT) and total mesorectal excision (TME), the development of distant metastases is the predominant mode of failure in rectal cancer patients today. Integrating more effective systemic therapy into combined modality programs is the challenge. The question that needs to be addressed is how and when to apply systemic treatment with adequate dose and intensity.